remap-cap

Using an innovative trial design to efficiently evaluate multiple interventions simultaneously. Research is in our DNA #remapcapfamily

[remap-cap @remap_cap]

REMAP-CAP's @DerdeLennie adds her voice to a beautiful celebration of #InternationalDayofWomenandGirlsinScience 👇

[remap-cap @remap_cap]

REMAP-CAP expanded immensely during the #COVID19 #pandemic, but in many regions it predates that period.

🇯🇵 @RemapCap Japan commenced in 2020 & has had an outsized impact on #clinicalresearch in the country, paving the way for other adaptive platform trials.

#10YearsREMAPCAP

[remap-cap @remap_cap]

🫁 Today we mark #WorldPneumoniaDay2024.

The #remapcapfamily has been tackling community-acquired #pneumonia for a decade now, and our joint efforts have positively impacted many lives around the world.

#10YearsREMAPCAP

#infectiousdiseases #clinicalresearch #covid19

[remap-cap @remap_cap]

Keeping patients, their families and the public engaged is a strength of REMAP-CAP.

🇵🇰 The Pakistani Patient & Public Involvement & Engagement group's 2024 summit gained national news coverage and presented networking opportunities.

👉 https://t.co/9somk69lvW

#10YearsREMAPCAP

[Timo Tolppa @TimoTolppa]

Empowering Patients - Revising Informed Consent Processes for Critical Care Trials in Pakistan

Our public group has worked with us to make informed consent for @MegaROXtrial and @remap_cap more culturally sensitive and relevant in the Pakistani context

[Timo Tolppa @TimoTolppa]

What does being a pragmatic trial mean in South Asia?

We evaluated 3 international trials (@remap_cap @MegaROXtrial RECOVERY)

Absent post-discharge follow up and poor physician and public understanding of trials constrained their incorporation into usual care

[remap-cap @remap_cap]

Our friends at the Dutch hospital @UMCU_Intl highlight REMAP-CAP's exceptional contribution to tackling community-acquired #pneumonia & #COVID19 🫁

Read the article 👉 https://t.co/h8eIO6fLbz

#10YearsREMAPCAP

@Lennie333 @MarcBonten @IenI_UMCUtrecht

[remap-cap @remap_cap]

REMAP-CAP team members attended the Federated Platform Trials meeting in Dublin organised by @ICCCTN, @ISARIC1 & @AcuteCareTrials.

The focus was on principles to enable platform #clinicaltrials to federate effectively, particularly in the field of #criticalcare.

[Wye Valley Trust Research Team @WVT_Research]

Thank you to our fantastic ICU team on #Red4Research day for their ongoing support with Clinical Trials @Airways_3 @AbbruptTrial @GenomiccStudy @iRehabTrial @remap_cap ❤️

[remap-cap @remap_cap]

🇵🇰 @Zuedu is one of 7 sites in Pakistan currently participating in REMAP-CAP.

Its Patient and Public Involvement & Engagement group recently produced a great video explaining #clinicaltrials in Urdu and with locally relevant graphics.

Check it out 👉 https://t.co/QMqTDuKuJV

[remap-cap @remap_cap]

🚩 Major REMAP-CAP milestone: 14.000 patients have been enrolled in the trial globally.

A big THANK YOU to the whole #remapcapfamily for the dedication and commitment to improving outcomes for patients with community-acquired #pneumonia 👏🏻👏🏾👏🏼

#10YearsREMAPCAP

[remap-cap @remap_cap]

Attending the #ERSCongress2024? Join this postgrad course to hear @Lennie333 discuss the landscape of adaptive platform #clinicaltrials in #criticalcare and the REMAP-CAP trial 👇

@EuroRespSoc @UMCU_Intl @IenI_UMCUtrecht @EU_Commission

[ERS @EuroRespSoc]

EU project sessions at the #ERSCongress2024

Join the experts on 7 September at 14:00 CEST for PG10 Postgraduate course Management of respiratory infection: lessons learnt from @Ecraid-Base clinical trials.

Find out more: https://t.co/rLG2h5EsTv

[Critical Care Reviews @CritCareReviews]

There was a lot of discussion around the presentation of the @remap_cap steroids for non-COVID community-acquired pneumonia domain results at #CCR24

Steve Webb from @anzicsctg & Scott Berry from @BerryConsultant discuss their findings

The data are presently unpublished

[remap-cap @remap_cap]

Those working on the REMAP-CAP trial in Europe are eligible for an attendance grant from @Ecraid. Follow the link below for details on how to apply 👇

[remap-cap @remap_cap]

Professor Anthony Gordon, REMAP-CAP's UK Chief Investigator, has been awarded an MBE (Member of the Order of the British Empire) for his contribution to #criticalcare.

Congratulations on this important recognition, @agordonICU 👏

https://t.co/ru6ErGi4gH @imperialcollege

[remap-cap @remap_cap]

🏁 @CritCareReviews Meeting 2024 begins tomorrow!

🚩 Among the 11 major trial results to be presented at #CCR24 are REMAP-CAP findings. Don't miss our exciting presentations.

▶️ Not attending? Watch the free livestream at https://t.co/cMHeO2wwIm

[remap-cap @remap_cap]

REMAP-CAP was highlighted by @ThwaitesGuy as "a trial that really matters". Watch his #ESCMIDGlobal presentation online 👇

[remap-cap @remap_cap]

#CCR24 kicks off in 7 days! Don't miss the REMAP-CAP presentations:

💊 Statins Trial Review
💊 Ivermectin Trial Results
💊 Steroids Trial Results

Check out the full programme 👉 https://t.co/MSokXL1VBN

Support @CritCareReviews 👉 https://t.co/v3q1Iw6l2R

[Giovanni Landoni, MD @giovannilandoni]

how did it go?

impressive summary of @remap_cap findings

#PratoAnaes2024

@stephen_t_webb @pinkney_t @KBibbinsDomingo @jocalynclark @HughHemmings @TWSnelling @HeliScottpterDr @yeung_joyce

https://t.co/vjcAvde3c5

[remap-cap @remap_cap]

IMPRINT will investigate drugs used for severe #COVID19 in patients with severe #pneumonia due to #influenza 🫁

The study will be integrated in the Influenza Immune Modulation Domain of REMAP-CAP.

Read more 👉 https://t.co/9R4DzO2qiH

@UMCU_Intl @IenI_UMCUtrecht @Ecraid @ZonMw